Paramount Bed Holdings Co (7817) AI Stock Analysis

• Market Cap: ¥189.51B
• Dividend Yield: 3.16%
• Average Volume (3M): 419.80K
• Price to Earnings (P/E): 21.7
• Beta (1Y): 0.63
• Revenue Growth: 1.96%
• EPS Growth: 22.78%
• Country: JP
• Employees: 4,126
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 22.95
• Shares Outstanding: 57,598,694
• 10 Day Avg. Volume: 388,920
• 30 Day Avg. Volume: 419,800
• PEG Ratio: -1.22
• Price to Book (P/B): 1.03
• Price to Sales (P/S): 1.31
• P/FCF Ratio: 17.53
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 76 Outperform
• Price Target: ¥4,006.00 ▲(14.29% Upside)

Paramount Bed Holdings Co receives a strong overall score due to its robust financial performance, characterized by solid revenue growth, profitability, and a strong balance sheet. The technical analysis indicates bullish momentum, although the high RSI suggests caution. The valuation is reasonable, supported by a decent dividend yield. The absence of earnings call and corporate events data does not impact the score.

Positive Factors

Revenue Growth

Consistent revenue growth indicates a strong market position and effective product demand, supporting long-term business sustainability.

Balance Sheet Strength

A strong balance sheet with low leverage provides financial stability and flexibility, enabling strategic investments and risk management.

Cash Flow Position

Positive operating cash flow supports operational needs and investment activities, ensuring the company can sustain growth and innovation.

Negative Factors

EPS Decline

A decline in EPS growth can indicate challenges in profitability, potentially impacting investor confidence and future earnings potential.

Free Cash Flow Volatility

Volatility in free cash flow may affect the company's ability to consistently fund new projects and return capital to shareholders.

Net Profit Margin Decline

A declining net profit margin could signal rising costs or pricing pressures, potentially impacting long-term profitability.

Paramount Bed Holdings Co Business Overview & Revenue Model

Company Description

Paramount Bed Holdings Co., Ltd. manufactures and sells hospital and nursing care beds worldwide. The company offers mattresses and equipment for medical treatment and nursing care environments; and home care products. It also engages in the inspection and maintenance of Paramount bed products; and leasing and wholesale of welfare care products. The company was founded in 1947 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Paramount Bed Holdings generates revenue through the sale of its medical and nursing care products, which are sold to healthcare facilities and institutions. The company's revenue model primarily relies on direct sales to hospitals and nursing homes, with a focus on innovative, high-quality products that meet the evolving needs of the healthcare sector. Additionally, the company benefits from service contracts and maintenance agreements for its products, which provide a recurring revenue stream. Strategic partnerships with healthcare providers and distributors further enhance its market reach and influence. The increasing demand for advanced medical equipment and the growing elderly population also contribute significantly to its earnings.

Paramount Bed Holdings Co Financial Statement Overview

Summary

Paramount Bed Holdings Co is financially robust, with strong revenue growth and profitability. The company maintains a solid balance sheet with low leverage and high equity, ensuring stability and flexibility. While the cash flow is positive, some volatility in free cash flow growth suggests the need for careful capital management. Overall, the company is well-positioned for continued growth and resilience in the medical instruments and supplies industry.

Income Statement

Paramount Bed Holdings Co demonstrates strong financial performance with a consistent growth trajectory. The gross profit margin has improved significantly over the years, indicating efficient cost management. The net profit margin remains robust, though it shows a slight decline in the latest year. Revenue growth is steady, reflecting the company's strong market position. EBIT and EBITDA margins are healthy, suggesting strong operational efficiency.

Balance Sheet

The company showcases a strong balance sheet with a low debt-to-equity ratio, indicating conservative financial leverage. The return on equity is impressive, reflecting effective management of shareholder funds. The equity ratio is high, suggesting a solid financial foundation and stability. Overall, the balance sheet supports the company's growth and risk management strategies.

Cash Flow

Paramount Bed Holdings Co's cash flow statement reveals a positive trend in operating cash flow, which covers net income well. The free cash flow has shown growth, although it remains somewhat volatile due to fluctuating capital expenditures. Despite this, the company's cash flow position supports its operational needs and investment activities effectively.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	107.69B	108.58B	106.02B	99.01B	90.35B	87.17B
Gross Profit	52.43B	52.56B	50.63B	47.20B	43.03B	40.44B
EBITDA	21.52B	24.14B	25.38B	22.45B	21.50B	20.55B
Net Income	8.60B	9.08B	10.62B	9.21B	9.09B	8.61B
Balance Sheet
Total Assets	176.02B	183.03B	180.02B	172.29B	164.28B	154.36B
Cash, Cash Equivalents and Short-Term Investments	42.32B	43.54B	46.75B	53.23B	54.07B	48.36B
Total Debt	7.23B	6.80B	5.96B	5.51B	6.13B	7.13B
Total Liabilities	41.16B	45.74B	44.01B	43.60B	42.61B	40.54B
Stockholders Equity	134.86B	137.28B	136.01B	128.69B	121.67B	113.82B
Cash Flow
Free Cash Flow	0.00	8.09B	3.29B	5.35B	6.30B	6.56B
Operating Cash Flow	0.00	10.45B	7.52B	9.15B	7.82B	10.28B
Investing Cash Flow	0.00	264.00M	-8.16B	-6.33B	-220.00M	-1.54B
Financing Cash Flow	0.00	-8.80B	-5.97B	-3.23B	-3.37B	-3.04B

Paramount Bed Holdings Co Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 3505.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7817, the sentiment is Positive. The current price of 3505 is below the 20-day moving average (MA) of 3508.25, below the 50-day MA of 3507.30, and above the 200-day MA of 2969.80, indicating a bullish trend. The MACD of 1.62 indicates Negative momentum. The RSI at 52.62 is Neutral, neither overbought nor oversold. The STOCH value of 44.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7817.

Paramount Bed Holdings Co Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7817	76 Outperform	¥189.51B	21.67	6.47%	3.16%	1.96%	22.78%
3360	75 Outperform	¥221.62B	15.95	10.19%	2.19%	8.90%	-3.71%
7716	66 Neutral	¥182.50B	27.08	5.66%	2.66%	5.43%	-20.67%
8086	62 Neutral	¥231.60B	21.27	4.38%	2.03%	6.04%	733.13%
3593	55 Neutral	¥144.24B	649.74	0.78%	1.31%	-2.06%	-79.17%
7702	54 Neutral	¥10.70B	68.49	―	3.85%	0.38%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Paramount Bed Holdings Co Corporate Events

Paramount Bed Holdings Announces Treasury Share Cancellation

Paramount Bed Holdings Co., Ltd. announced its decision to cancel 1,522,853 treasury shares, representing 2.64% of its total issued shares, contingent upon shareholder approval of a share consolidation proposal. This move, scheduled for February 6, 2026, aims to streamline the company’s capital structure and potentially enhance shareholder value.

The most recent analyst rating on (JP:7817) stock is a Buy with a Yen4006.00 price target. To see the full list of analyst forecasts on Paramount Bed Holdings Co stock, see the JP:7817 Stock Forecast page.

Paramount Bed Holdings Announces Share Consolidation and Delisting

Paramount Bed Holdings Co., Ltd. announced a series of strategic changes, including a share consolidation and amendments to its Articles of Incorporation, as part of a management buyout (MBO) led by TMKR Co., Ltd. This move will result in the delisting of the company’s shares from the Tokyo Stock Exchange Prime Market in February 2026. The decision is aimed at privatizing the company and is expected to impact its market presence and shareholder structure significantly.

The most recent analyst rating on (JP:7817) stock is a Buy with a Yen4006.00 price target. To see the full list of analyst forecasts on Paramount Bed Holdings Co stock, see the JP:7817 Stock Forecast page.

Paramount Bed Holdings Announces Successful Tender Offer and Change in Major Shareholder

Paramount Bed Holdings Co., Ltd. announced the successful completion of a tender offer for its shares by TMKR Co., Ltd., which will result in TMKR becoming the new parent company and largest shareholder. This change, effective November 25, 2025, will see TMKR, backed by CTOK Co., Ltd., holding over 50% of the voting rights, potentially impacting the company’s strategic direction and shareholder dynamics.

The most recent analyst rating on (JP:7817) stock is a Buy with a Yen4006.00 price target. To see the full list of analyst forecasts on Paramount Bed Holdings Co stock, see the JP:7817 Stock Forecast page.

Paramount Bed Holdings Prepares for Potential Shareholders’ Meeting Amid Tender Offer

Paramount Bed Holdings Co., Ltd. has announced the establishment of a record date for a potential Extraordinary Shareholders’ Meeting in January 2026. This meeting is contingent upon the outcome of a tender offer by TMKR Co., Ltd. for the company’s shares, which could lead to the delisting of the company’s shares and a consolidation of ownership among a select group of shareholders. The decision to set a record date is a preparatory step, and the meeting will only proceed if the tender offer does not result in the acquisition of all shares by the Offeror.

The most recent analyst rating on (JP:7817) stock is a Buy with a Yen4006.00 price target. To see the full list of analyst forecasts on Paramount Bed Holdings Co stock, see the JP:7817 Stock Forecast page.

Paramount Bed Holdings Reports Mixed Financial Results for First Half of Fiscal Year

Paramount Bed Holdings Co., Ltd. reported a decrease in net sales and operating profit for the first six months of the fiscal year ending March 31, 2026, compared to the previous year. Despite this, the company saw an increase in profit attributable to owners of the parent, indicating some resilience in its financial performance. The company maintains a strong equity-to-asset ratio, reflecting financial stability, but has announced a suspension of dividend payments for the fiscal year, which may impact shareholder returns.

The most recent analyst rating on (JP:7817) stock is a Buy with a Yen4006.00 price target. To see the full list of analyst forecasts on Paramount Bed Holdings Co stock, see the JP:7817 Stock Forecast page.